{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:31:45Z","timestamp":1784759505241,"version":"3.55.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014181","name":"Junta de Extremadura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmech.2026.118791","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:56:06Z","timestamp":1774486566000},"page":"118791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Memantine: A look ahead. Insights into structure, syntheses, receptor binding mechanisms, drug hybrids and formulations, and potential repurposing"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-6074","authenticated-orcid":false,"given":"R. Fernando","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8385-6264","authenticated-orcid":false,"given":"Mar\u00eda","family":"S\u00e1nchez-Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-3604","authenticated-orcid":false,"given":"Pedro","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10043","key":"10.1016\/j.ejmech.2026.118791_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118791_bib2","series-title":"World Alzheimer Report 2023: Reducing Dementia Risk: Never Too Early, Never Too Late","author":"Long","year":"2023"},{"key":"10.1016\/j.ejmech.2026.118791_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/d41573-024-00001-x","article-title":"FDA approvals","volume":"23","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"36","key":"10.1016\/j.ejmech.2026.118791_bib4","first-page":"28","article-title":"Is this a golden age of small-molecule drug discovery?","volume":"101","author":"Howes","year":"2023","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.ejmech.2026.118791_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","article-title":"Update on Alzheimer's disease therapy and prevention strategies","volume":"68","author":"Graham","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2026.118791_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/acschemneuro.8b00517","article-title":"Classics in chemical neuroscience: donepezil","volume":"10","author":"Brewster","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jmedchem.0c01863","article-title":"Kinetics-driven drug design strategy for next-generation acetylcholinesterase inhibitors to clinical candidate","volume":"64","author":"Zhou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd1311","article-title":"Memantine hydrochloride","volume":"3","author":"Witt","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118791_bib9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ejmech.2011.01.047","article-title":"The many faces of the adamantyl group in drug design","volume":"46","author":"Liu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib10","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/cr100264t","article-title":"The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives","volume":"113","author":"Wanka","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.118791_bib11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschemneuro.7b00270","article-title":"Classics in chemical neuroscience: memantine","volume":"8","author":"Alam","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib12","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/molecules25174005","article-title":"Memantine derivatives as multitarget agents in Alzheimer's disease","volume":"25","author":"Marotta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118791_bib13","series-title":"Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease","first-page":"185","article-title":"Memantine-based derivatives: synthesis and their biological evaluation","author":"Kumar","year":"2023"},{"key":"10.1016\/j.ejmech.2026.118791_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117592","article-title":"The adamantane scaffold: beyond a lipophilic moiety","volume":"291","author":"Dane","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14638","article-title":"Recent advances in medicinal chemistry of memantine against Alzheimer's disease","volume":"104","author":"Singh","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.118791_bib16","article-title":"Memantine: updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Tari","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118791_bib17","first-page":"1204","volume":"vol. 67","author":"Eliel","year":"1994"},{"key":"10.1016\/j.ejmech.2026.118791_bib18","series-title":"Stereochemistry Workbook","first-page":"166","author":"Hellwich","year":"2006"},{"key":"10.1016\/j.ejmech.2026.118791_bib19","series-title":"Adamantyl Secondary Amines. Patent US 3391142 A","author":"Mills","year":"1968"},{"key":"10.1016\/j.ejmech.2026.118791_bib20","series-title":"Drugs or Medicines for Influencing the Central Nervous System","author":"Scherm","year":"1978"},{"key":"10.1016\/j.ejmech.2026.118791_bib21","series-title":"Crystal Form II of Memantine Hydrochloride","author":"Punju","year":"2005"},{"key":"10.1016\/j.ejmech.2026.118791_bib22","series-title":"Process for the Preparation of 1-amino-3,5-dimethyladamantane Hydrochloride","author":"Merli","year":"2006"},{"key":"10.1016\/j.ejmech.2026.118791_bib23","series-title":"Polymorphs of Memantine Hydrochloride. Patent WO2006\/076560 A1","author":"Merli","year":"2006"},{"key":"10.1016\/j.ejmech.2026.118791_bib24","series-title":"Process for the Preparation of Memantine and its Hydrochloric Acid Salt Form","author":"Tihi","year":"2008"},{"key":"10.1016\/j.ejmech.2026.118791_bib26","article-title":"Memantinium chloride 0.1-hydrate","volume":"E65","author":"Lou","year":"2009","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118791_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1134\/S0022476617030271","article-title":"Structure of 3,5-dimethyl-1-adamantanamine-2,4,6-triisopropylbenzosulphonate salt in the crystal","volume":"58","author":"Tkachev","year":"2017","journal-title":"J. Struct. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1107\/S2056989019009988","article-title":"(3,5-Dimethyladamantan-1-yl)ammonium methanesulfonate (memantinium mesylate): synthesis, structure and solid-state properties","volume":"E75","author":"Tuksar","year":"2019","journal-title":"Acta Crystallogr. E Crystallogr. Commun."},{"key":"10.1016\/j.ejmech.2026.118791_bib29","first-page":"543","article-title":"Crystal structure of memantine\u2212carboxyborane","volume":"E75","author":"Ayudhya","year":"2019","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118791_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127672","article-title":"A series of memantine based salts with various aromatic and aliphatic carboxylic acids: crystallographic analysis, Hirshfeld surfaces and dissolution study","volume":"1206","author":"Bhardwaj","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118791_bib31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/acs.molpharmaceut.1c00931","article-title":"Insoluble salt of memantine with a unique fluorescence phenomenon","volume":"19","author":"Kuang","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib32","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1021\/acs.molpharmaceut.4c00670","article-title":"Exploring salts of memantine with inorganic anions: from polymorphism and solid-state transitions to potential for drug formulations","volume":"21","author":"Tuksar","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2025.134517","article-title":"Unraveling the synthesis and therapeutic potential of FDA-approved Alzheimer's drugs: a comprehensive review","volume":"175","author":"Rani","year":"2025","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.118791_bib34","series-title":"Aminoadamantan-derivate, verfahren zur ihrer herstellung und ihre verwendung","author":"Schreiner","year":"2006"},{"key":"10.1016\/j.ejmech.2026.118791_bib35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ejoc.200600975","article-title":"\u03b3-Aminoadamantanecarboxylic acids through direct C-H bond amidations","author":"Wanka","year":"2007","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib36","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1021\/acsomega.0c01589","article-title":"Simple two-step procedure for the synthesis of memantine hydrochloride from 1,3-dimethyladamantane","volume":"5","author":"Vu","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.118791_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/00304948.2020.1785807","article-title":"An improved synthesis of memantine hydrochloride","volume":"52","author":"Vu","year":"2020","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2026.118791_bib38","first-page":"6370","article-title":"A concise two-step method for preparation of memantine hydrochloride from 1,3-dimethyladamantane","volume":"12","author":"Nguyen","year":"2021","journal-title":"Int. J. Pharma Sci. Res."},{"key":"10.1016\/j.ejmech.2026.118791_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14233\/ajchem.2022.23447","article-title":"Two step cost-saving process for industrial scale production of 1-amino-3,5-dimethyladamantane hydrochloride (an anti-Alzheimer\u2019s drug)","volume":"34","author":"Nguyen","year":"2022","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00304948.2017.1291004","article-title":"Convenient synthesis of memantine hydrochloride","volume":"49","author":"Ivleva","year":"2017","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2026.118791_bib41","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1002\/anie.201901673","article-title":"Intermolecular radical Csp3-H amination under iodine catalysis","volume":"58","author":"Bosnidou","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118791_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202403562","article-title":"Development of continuous-flow reactions for the synthesis of anti-Alzheimer drug memantine","volume":"31","author":"Iwata","year":"2025","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.118791_bib43","series-title":"Handbook of Receptors and Biological Effects","first-page":"107","article-title":"Neurotransmitters and neuromodulators","author":"Von Bohlen und Halbach","year":"2006"},{"key":"10.1016\/j.ejmech.2026.118791_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118791_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","article-title":"Pharmacodynamics of memantine: an update","volume":"6","author":"Parsons","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2026.118791_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib47","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.118791_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2174\/1381612024607117","article-title":"Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists","volume":"8","author":"Danysz","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.118791_bib49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/pharmaceutics12030284","article-title":"A novel NMDA receptor antagonist protects against cognitive decline presented by senescent mice","volume":"12","author":"Companys-Alemany","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.118791_bib50","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118791_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41594-022-00772-0","article-title":"Structural insights into binding of therapeutic channel blockers in NMDA receptors","volume":"29","author":"Chou","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118791_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41586-024-07742-0","article-title":"Molecular mechanism of ligand gating and opening of NMDA receptor","volume":"632","author":"Chou","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118791_bib53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10571-017-0561-6","article-title":"Potentiation and block of ASIC1a by memantine","volume":"38","author":"Shteinikov","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.118791_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neuropharm.2018.05.017","article-title":"Effects of Mg2+ recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site","volume":"137","author":"Glasgow","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118791_bib55","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1038\/s41467-022-31817-z","article-title":"Inhibition of NMDA receptors through a membrane-to-channel path","volume":"13","author":"Wilcox","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118791_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mp.2016.187","article-title":"Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy","volume":"23","author":"Moriguchi","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2026.118791_bib57","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1038\/s41467-025-60543-5","article-title":"Memantine inhibits calcium permeable AMPA receptors","volume":"16","author":"Carrillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118791_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2417","article-title":"Memantine inhibits cortical spreading depolarization and improves neurovascular function following repetitive traumatic brain injury","volume":"9","author":"MacLean","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118791_bib59","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.adq5252","article-title":"The prion principle and Alzheimer's disease","volume":"385","author":"Walker","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118791_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2017.02.001","article-title":"Memantine reduces the production of amyloid-\u03b2 peptides through modulation of amyloid precursor protein trafficking","volume":"798","author":"Ito","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118791_bib61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbrc.2017.09.058","article-title":"Memantine inhibits \u03b2-amyloid aggregation and disassembles preformed \u03b2-amyloid aggregates","volume":"493","author":"Takahashi-Ito","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118791_bib62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/acs.jpcb.9b10368","article-title":"Amyloid peptide scaffolds coordinate with Alzheimer's disease drugs","volume":"124","author":"Jonnalagadda","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.118791_bib63","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1007\/s12035-019-01678-7","article-title":"Memantine, a noncompetitive N-methyl-D-aspartate receptor antagonist, attenuates cerebral amyloid angiopathy by increasing insulin-degrading enzyme expression","volume":"56","author":"Inoue","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.118791_bib64","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1021\/acs.biochem.0c00813","article-title":"In vitro effects of (+)MK-801 (dizocilpine) and memantine on \u03b2-amyloid peptides linked to Alzheimer's disease","volume":"59","author":"Coombs","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118791_bib65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acschemneuro.0c00811","article-title":"A\u03b2 oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors","volume":"12","author":"Fani","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib66","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschemneuro.4c00763","article-title":"Dysregulated neurotransmission and the role of viruses in Alzheimer's disease","volume":"16","author":"Bovis","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02524549","article-title":"Molecular-biological problems of drug design and mechanism of drug action. Adamantane derivatives: pharmacological and toxicological properties","volume":"34","author":"Spasov","year":"2000","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2026.118791_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib69","first-page":"57","article-title":"Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kyneurinic acid and mismatch negativity","volume":"5","author":"Koola","year":"2018","journal-title":"J. Geriat. Care Res."},{"key":"10.1016\/j.ejmech.2026.118791_bib70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2017.04.051","article-title":"DNA damage, DNA susceptibility to oxidation and glutathione redox status in patients with Alzheimer's disease treated with and without memantine","volume":"378","author":"Akkaya","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s43856-024-00527-6","article-title":"Combined use of donepezil and memantine increases the probability of five-year survival of Alzheimer's disease patients","volume":"4","author":"Yaghmaei","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.ejmech.2026.118791_bib72","article-title":"Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer's disease","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118791_bib73","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/acs.molpharmaceut.8b00176","article-title":"In depth analysis of pressure-sensitive adhesive patch-assisted delivery of memantine and donepezil using physiologically based pharmacokinetic modeling and in vitro\/in vivo correlations","volume":"15","author":"Mittapelly","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","article-title":"Memantine nanoemulsion: a new approach to treat Alzheimer's disease","volume":"37","author":"Kaur","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejmech.2026.118791_bib75","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1177\/0885328219890071","article-title":"Gamma radiation preparation of chitosan nanoparticles for controlled delivery of memantine","volume":"34","author":"Radwan","year":"2020","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejmech.2026.118791_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105331","article-title":"Nanoporous microneedle arrays seamlessly connected to a drug reservoir for tunable transdermal delivery of memantine","volume":"150","author":"Vos","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib77","series-title":"Manufacture and Preparation of Stabilized Combined Multistage Compositions of Memantine HCl Extended Release and Donepezil HCl Immediate Release Pellets","author":"Pathuru","year":"2021"},{"key":"10.1016\/j.ejmech.2026.118791_bib78","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1021\/acs.molpharmaceut.3c00454","article-title":"Simultaneous intranasal codelivery of donepezil and memantine in a nanocolloidal carrier: optimization, pharmacokinetics, and pharmacodynamics studies","volume":"20","author":"Handa","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib79","article-title":"In vivo evaluation of nose-to-brain delivery of liposomal donepezil, memantine, and BACE-1 siRNA for Alzheimer's disease therapy","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/cryst13010021","article-title":"Preparation of memantine-loaded chitosan nanocrystals: in vitro and ex vivo toxicity analysis","volume":"13","author":"Saleh","year":"2023","journal-title":"Crystals"},{"key":"10.1016\/j.ejmech.2026.118791_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.03.022","article-title":"A pharmaceutical answer to nonadherence: once weekly oral memantine for Alzheimer's disease","volume":"303","author":"Kanasty","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.118791_bib82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization","volume":"16","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2026.118791_bib83","article-title":"Preparation and in vitro characterization of memantine HCl loaded PLGA nanoparticles for Alzheimer's disease","volume":"100","author":"Tezel","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2026.118791_bib84","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/abac35","article-title":"Magnetic nanoemulsions as candidates for Alzheimer's disease dual imaging theranostics","volume":"31","author":"Antonoglou","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejmech.2026.118791_bib85","series-title":"Novel Adamantane and Memantine Derivatives as Peripheral NMDA Receptor Antagonists and their Preparation. Patent WO2017 017116 A1","author":"Humbert","year":"2017"},{"key":"10.1016\/j.ejmech.2026.118791_bib86","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2016.11.020","article-title":"Multi-target-directed therapeutic potential of 7-methoxyacrine-adamantylamine heterodimers in the Alzheimer's disease treatment","volume":"1863","author":"Gazova","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2026.118791_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115803","article-title":"Galantamine-memantine hybrids for Alzheimer's disease: the influence of linker rigidity in biological activity and pharmacokinetic properties","volume":"261","author":"Basagni","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib88","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1021\/acs.molpharmaceut.9b00252","article-title":"Controlled iontophoretic delivery in vitro and in vivo of ARN14140 \u2013 a multitarget compound for Alzheimer's disease","volume":"16","author":"Singhal","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib89","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bmc.2017.12.021","article-title":"Design, synthesis, and evaluation of polyamine-memantine hybrids as NMDA channel blockers","volume":"26","author":"Kumamoto","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib90","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1016\/j.bmcl.2007.06.069","article-title":"Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers","volume":"17","author":"Takayama","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118791_bib91","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acschemneuro.2c00300","article-title":"Novel multipotent amantadine-M30D hybrids with highly selective butyrylcholinesterase inhibition and neuroprotective effects as effective anti-Alzheimer\u2019s agents","volume":"13","author":"Rada","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/02652048.2023.2167011","article-title":"Polymer drug conjugates containing memantine, tacrine and cinnamic acid: promising nanotherapeutics for the treatment of Alzheimer's disease","volume":"40","author":"Naki","year":"2023","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejmech.2026.118791_bib93","doi-asserted-by":"crossref","first-page":"11678","DOI":"10.1021\/acsomega.1c06571","article-title":"Memantine-derived Schiff bases as transdermal prodrug candidates","volume":"7","author":"Araujo de Oliveira","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.118791_bib94","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/acs.molpharmaceut.1c00931","article-title":"Insoluble salt of memantine with a unique fluorescence phenomenon","volume":"19","author":"Kuang","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcis.2022.02.124","article-title":"Drug delivery of memantine with carbon dots for Alzheimer's disease: blood-brain barrier penetration and inhibition of tau aggregation","volume":"617","author":"Zhang","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib96","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1021\/acs.molpharmaceut.5c00277","article-title":"Nanomedicine for treating major brain diseases: advances and future directions","volume":"22","author":"Sagar","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118791_bib97","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.jmedchem.4c03049","article-title":"Unlocking the therapeutic potential of natural products for Alzheimer's disease","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib98","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/acschemneuro.5c00207","article-title":"Alzheimer's disease: a review of molecular mechanisms and therapeutic implications by targeting sirtuins, caspases, and CSK-3","volume":"16","author":"Pandya","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib99","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejps.2017.08.030","article-title":"Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma","volume":"109","author":"Cacciatore","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bmcl.2018.01.019","article-title":"Triptolide derivatives as potential anti-Alzheimer agents: synthesis and structure-activity relationship studies","volume":"28","author":"Ning","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118791_bib101","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.07.011","article-title":"Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-\u03b2 peptide in Alzheimer's disease","volume":"180","author":"Rosini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib102","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00726-020-02914-4","article-title":"Synthetic analogs of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies","volume":"52","author":"Tencheva","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2026.118791_bib103","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/ph15091108","article-title":"Synthesis, neuroprotective effect and physicochemical studies of novel peptide and nootropic analogues of Alzheimer disease drug","volume":"15","author":"Chayrov","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118791_bib104","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s11172-016-1461-5","article-title":"Molecular design of multitarget neuroprotector 3. Synthesis and bioactivity of tetrahydrocarbazole-aminoadamantane conjugates","volume":"65","author":"Sokolov","year":"2016","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2026.118791_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejps.2013.02.013","article-title":"Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease","volume":"49","author":"Sozio","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.118791_bib106","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/acschemneuro.5c00493","article-title":"Donepezil and memantine derivatives for dual-function and prodrug applications in Alzheimer's disease","volume":"16","author":"Terpstra","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ijnp\/pyab007","article-title":"Fluoroethylnormemantine, a novel derivative of memantine facilitates extinction learning without sensorimotor deficits","volume":"24","author":"Chen","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2026.118791_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109733","article-title":"Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease","volume":"242","author":"Freyssin","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118791_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-024-01648-9","article-title":"Neuroprotection by chronic administration of fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease","volume":"17","author":"Carles","year":"2025","journal-title":"Alzh. Res. Therapy"},{"key":"10.1016\/j.ejmech.2026.118791_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114354","article-title":"Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease","volume":"236","author":"Turcu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118791_bib111","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1021\/acsmedchemlett.9b00155","article-title":"DABMA: a derivative of ABMA with improved broad-spectrum inhibitory activity of toxins and viruses","volume":"10","author":"Wu","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118791_bib112","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41598-019-40925-8","article-title":"Memantine prodrug as a new agent for Alzheimer's disease","volume":"9","author":"Sestito","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118791_bib113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1039\/C6MD00509H","article-title":"Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases","volume":"8","author":"Liu","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2026.118791_bib114","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/acschemneuro.9b00242","article-title":"Pharmacological characterization of anti-dementia memantine nitrate via neuroprotection and vasodilation in vitro and in vivo","volume":"11","author":"Mak","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.niox.2017.10.001","article-title":"Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones","volume":"79","author":"Altinoz","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2026.118791_bib116","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ceca.2009.12.009","article-title":"Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies","volume":"47","author":"Nakamura","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejmech.2026.118791_bib117","first-page":"367","article-title":"Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias","volume":"4","author":"Thomas","year":"2009","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejmech.2026.118791_bib118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00109-020-01982-z","article-title":"Memantine in neurological disorders \u2013 schizophrenia and depression","volume":"99","author":"Czarnecka","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118791_bib119","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjh.19912","article-title":"From old to new: repurposed drugs in the battle towards curing sickle cell disease","volume":"206","author":"Hoss","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2026.118791_bib120","article-title":"Neuroprotective and intraocular pressure lowering effects of dual-functional memantine nitrate MN-08 on the experimental models of glaucoma","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118791_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-94760-1","article-title":"Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1\/2-Nrf2-caspase-3 signaling pathway","volume":"15","author":"Mohyeldin","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118791_bib122","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(24)00326-0","article-title":"Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomized, adaptive platform trial","volume":"23","author":"Pal","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2026.118791_bib123","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acschemneuro.5c00446","article-title":"Alzheimer's is not a single disease","volume":"16","author":"Weaver","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118791_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads3204","article-title":"Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA","volume":"389","author":"Pizzo","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118791_bib125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer's disease","volume":"645","author":"Aron","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118791_bib126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/d41573-024-00017-3","article-title":"Open science in precision medicine for neurodegenerative diseases","volume":"23","author":"Leonard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118791_bib127","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41591-025-03835-z","article-title":"APOE \u03b54 carries share immune-related proteomic changes across neurodegenerative diseases","volume":"31","author":"Shvetcov","year":"2025","journal-title":"Nat. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:18:36Z","timestamp":1776118716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":126,"alternative-id":["S0223523426002369"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118791","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Memantine: A look ahead. Insights into structure, syntheses, receptor binding mechanisms, drug hybrids and formulations, and potential repurposing","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118791"}}